| 2701 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
8 |
| 2702 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2703 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
20 |
| 2704 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2705 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2706 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2707 |
Bone Marrow |
Allogeneic |
Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2708 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2709 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2710 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2711 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2712 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 2713 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
44 |
| 2714 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2715 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
75 |
| 2716 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
61 |
| 2717 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
41 |
| 2718 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
23 |
| 2719 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
36 |
| 2720 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
17 |
| 2721 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 2722 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 2723 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 2724 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2725 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
58 |
| 2726 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2727 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
25 |
| 2728 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
30 |
| 2729 |
Bone Marrow |
Allogeneic |
Acute Myeloid Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2730 |
Bone Marrow |
Allogeneic |
Adenosine Deaminase Deficient Severe Combined Immunodeficiency (Ada-Scid) |
Hematology |
2022 |
Standard Therapy |
Poland |
3 months |
| 2731 |
Bone Marrow |
Allogeneic |
Amyloidosis |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2732 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
19 |
| 2733 |
Bone Marrow |
Allogeneic |
Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2734 |
Bone Marrow |
Allogeneic |
B-Cell Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2735 |
Bone Marrow |
Allogeneic |
Bone Marrow Failure Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2736 |
Bone Marrow |
Allogeneic |
Chediak-Higashi-Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2737 |
Bone Marrow |
Allogeneic |
Chronic Granulomatous Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
37 |
| 2738 |
Bone Marrow |
Allogeneic |
Combined Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
7 |
| 2739 |
Bone Marrow |
Allogeneic |
Common Variable Immunodeficiency With Granulomatous-Lymphocytic Interstitial Lung Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2740 |
Bone Marrow |
Allogeneic |
Diamond Blackfan Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2741 |
Bone Marrow |
Allogeneic |
Diamond Blackfan Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
4 |
| 2742 |
Bone Marrow |
Allogeneic |
Dock8 Deficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2743 |
Bone Marrow |
Allogeneic |
Early Isolated All Bm Relapse |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2744 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
5 |
| 2745 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
7 |
| 2746 |
Bone Marrow |
Allogeneic |
Fanconi Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2747 |
Bone Marrow |
Allogeneic |
Griscelli Syndrome Type 2 |
Hematology |
2022 |
Standard Therapy |
Poland |
2 months |
| 2748 |
Bone Marrow |
Allogeneic |
Hemophagocytic Lymphocytosis |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2749 |
Bone Marrow |
Allogeneic |
Hemophagocytic Lymphohistiocytosis (Hlh) |
Hematology |
2022 |
Standard Therapy |
Poland |
46 |
| 2750 |
Bone Marrow |
Allogeneic |
Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
57 |
| 2751 |
Bone Marrow |
Allogeneic |
Infant Acute Lymphoblastic Leukemia With Kmt2a Gene Rearrangement |
Hematology |
2022 |
Standard Therapy |
Poland |
7 months |
| 2752 |
Bone Marrow |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2753 |
Bone Marrow |
Allogeneic |
Juvenile Myelomonocytic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2754 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2755 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
16 |
| 2756 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
63 |
| 2757 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
64 |
| 2758 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
14 |
| 2759 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2760 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
51 |
| 2761 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
8 |
| 2762 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 2763 |
Bone Marrow |
Allogeneic |
Myelodysplastic Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 2764 |
Bone Marrow |
Allogeneic |
Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
56 |
| 2765 |
Bone Marrow |
Allogeneic |
Myelofibrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
17 |
| 2766 |
Bone Marrow |
Allogeneic |
Nhl (Non-Hodgkin's Lymphoma) |
Hematology |
2022 |
Standard Therapy |
Poland |
37 |
| 2767 |
Bone Marrow |
Allogeneic |
Nijmegen Breakage Syndrome |
Hematology |
2022 |
Standard Therapy |
Poland |
9 |
| 2768 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2022 |
Standard Therapy |
Poland |
13 |
| 2769 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2770 |
Bone Marrow |
Allogeneic |
No Data |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2771 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
53 |
| 2772 |
Bone Marrow |
Allogeneic |
Non-Hodgkin Lymphoma |
Hematology |
2022 |
Standard Therapy |
Poland |
37 |
| 2773 |
Bone Marrow |
Allogeneic |
Osteopetrosis |
Hematology |
2022 |
Standard Therapy |
Poland |
2 |
| 2774 |
Bone Marrow |
Allogeneic |
Other Immune System Disorders |
Hematology |
2022 |
Standard Therapy |
Poland |
1 |
| 2775 |
Bone Marrow |
Allogeneic |
Other Non-Malignant Disease |
Hematology |
2022 |
Standard Therapy |
Poland |
8 |
| 2776 |
Bone Marrow |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria (Pnh) |
Hematology |
2022 |
Standard Therapy |
Poland |
17 |
| 2777 |
Bone Marrow |
Allogeneic |
Paroxysmal Nocturnal Hemoglobinuria With Marrow Failure |
Hematology |
2022 |
Standard Therapy |
Poland |
10 |
| 2778 |
Bone Marrow |
Allogeneic |
Philadelphia-Positive Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2779 |
Bone Marrow |
Allogeneic |
Pre-B Acute Lymphoblastic Leukemia |
Hematology |
2022 |
Standard Therapy |
Poland |
32 |
| 2780 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
3 |
| 2781 |
Bone Marrow |
Allogeneic |
Primary Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
9 months |
| 2782 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
46 |
| 2783 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2784 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2785 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
65 |
| 2786 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
12 |
| 2787 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
68 |
| 2788 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
15 |
| 2789 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
18 |
| 2790 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2791 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
19 |
| 2792 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
6 |
| 2793 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2794 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
35 |
| 2795 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
11 |
| 2796 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
5 |
| 2797 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
30 |
| 2798 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
14 |
| 2799 |
Bone Marrow |
Allogeneic |
Severe Aplastic Anemia |
Hematology |
2022 |
Standard Therapy |
Poland |
49 |
| 2800 |
Bone Marrow |
Allogeneic |
Severe Combined Immunodeficiency |
Hematology |
2022 |
Standard Therapy |
Poland |
3 months |